1,242 UnitedHealth Group Incorporated $UNH Shares Acquired by Kingswood Wealth Advisors LLC

Kingswood Wealth Advisors LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.4% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 10,525 shares of the healthcare conglomerate’s stock after purchasing an additional 1,242 shares during the period. Kingswood Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $3,863,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. General Partner Inc. purchased a new stake in shares of UnitedHealth Group in the third quarter worth $512,000. PBCay One RSC Ltd purchased a new position in shares of UnitedHealth Group in the 1st quarter worth about $14,343,000. Lee Johnson Capital Management LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter worth about $6,180,000. Kinsale Capital Group Inc. boosted its stake in UnitedHealth Group by 13.4% in the 2nd quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate’s stock worth $16,006,000 after purchasing an additional 4,557 shares in the last quarter. Finally, Fideuram Intesa Sanpaolo Private Banking S.P.A. grew its position in UnitedHealth Group by 1,287.2% during the 1st quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. now owns 60,022 shares of the healthcare conglomerate’s stock valued at $16,241,000 after purchasing an additional 55,695 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.19% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on UNH shares. HSBC raised their price objective on shares of UnitedHealth Group from $300.00 to $380.00 and gave the company a “hold” rating in a research note on Monday, July 6th. Raymond James Financial reiterated an “outperform” rating and issued a $450.00 target price on shares of UnitedHealth Group in a research note on Thursday, October 15th. Robert W. Baird cut their price target on shares of UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating on the stock in a report on Wednesday, October 14th. New Street Research set a $402.00 price target on shares of UnitedHealth Group in a research report on Friday, October 9th. Finally, Stephens set a $500.00 price objective on shares of UnitedHealth Group in a report on Friday, October 16th. Twenty equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $463.80.

UnitedHealth Group Stock Performance

UNH stock opened at $410.81 on Tuesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The company has a market cap of $368.74 billion, a P/E ratio of 20.49, a price-to-earnings-growth ratio of 1.51 and a beta of 0.60. The stock’s fifty day moving average price is $388.57 and its 200-day moving average price is $360.79.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The company had revenue of $112.70 billion during the quarter, compared to analysts’ expectations of $111.31 billion. During the same quarter in the prior year, the business earned $2.59 earnings per share. UnitedHealth Group’s revenue for the quarter was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 20.62 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were given a dividend of $2.32 per share. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group’s dividend payout ratio is presently 53.00%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.